The findings suggest that CD36, IGF1, LPL, and UCP2 may serve as potential biomarkers for DKD.<h4>Conclusions</h4>The genes CD36, IGF1, LPL, and UCP2 represent potential energy metabolism-related biomarkers with possible applications in the diagnosis and treatment of DKD. The gene discussed is CD36; the disease is diabetic kidney disease.